KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to 9.4%.

  • Exact Sciences' EBIT Margin rose 1134300.0% to 9.4% in Q4 2025 from the same period last year, while for Dec 2025 it was 6.35%, marking a year-over-year increase of 316600.0%. This contributed to the annual value of 6.35% for FY2025, which is 316600.0% up from last year.
  • Per Exact Sciences' latest filing, its EBIT Margin stood at 9.4% for Q4 2025, which was up 1134300.0% from 3.0% recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' EBIT Margin ranged from a high of 1.09% in Q3 2023 and a low of 122.84% during Q4 2024
  • For the 5-year period, Exact Sciences' EBIT Margin averaged around 26.05%, with its median value being 15.16% (2024).
  • Its EBIT Margin has fluctuated over the past 5 years, first plummeted by -1123500bps in 2024, then surged by 1134300bps in 2025.
  • Over the past 5 years, Exact Sciences' EBIT Margin (Quarter) stood at 46.74% in 2021, then skyrocketed by 54bps to 21.5% in 2022, then soared by 51bps to 10.49% in 2023, then tumbled by -1071bps to 122.84% in 2024, then surged by 92bps to 9.4% in 2025.
  • Its EBIT Margin stands at 9.4% for Q4 2025, versus 3.0% for Q3 2025 and 0.26% for Q2 2025.